Potent and highly selective inhibition of the inducible nitric oxide synthase in vitro and in vivo by the novel imidazopyridine BYK191023

被引：0
|
作者：
Strub, A
Hesslinger, C
Lehner, MD
Ulrich, WR
Eltze, M
Fuchss, T
Boer, R
机构：
来源：
NITRIC OXIDE-BIOLOGY AND CHEMISTRY | 2006年 / 14卷 / 04期
关键词：
D O I：
10.1016/j.niox.2006.04.038
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A11 / A11
页数：1
相关论文
共 50 条
  • [1] BYK191023 is a NADPH- and time-dependent irreversible inhibitor of inducible nitric-oxide synthase
    Tiso, Mauro
    Strub, Andreas
    Hesslinger, Christian
    Kenney, Claire
    Boer, Rainer
    Stuehr, Dennis J.
    FREE RADICAL BIOLOGY AND MEDICINE, 2007, 43 : S33 - S33
  • [2] In vivo characterization of the novel imidazopyridine BYK191023 [2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine], a potent and highly selective inhibitor of inducible nitric-oxide synthase
    Lehner, MD
    Marx, D
    Boer, R
    Strub, A
    Hesslinger, C
    Eltze, M
    Wolf-Rüdiger, U
    Schwoebel, F
    Schermuly, RT
    Barsig, J
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 317 (01): : 181 - 187
  • [3] The novel imidazopyridine 2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine (BYK191023) is a highly selective inhibitor of the inducible nitric-oxide synthase
    Strub, A
    Ulrich, WR
    Hesslinger, C
    Eltze, M
    Fuchss, T
    Strassner, J
    Strand, S
    Lehner, MD
    Boer, R
    MOLECULAR PHARMACOLOGY, 2006, 69 (01) : 328 - 337
  • [4] The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS)
    Cheshire, David R.
    Aberg, Anders
    Andersson, Gunilla M. K.
    Andrews, Glen
    Beaton, Haydn G.
    Birkinshaw, Timothy N.
    Boughton-Smith, Nigel
    Connolly, Stephen
    Cook, Tony R.
    Cooper, Anne
    Cooper, Sally L.
    Cox, David
    Dixon, John
    Gensmantel, Nigel
    Hamley, Peter J.
    Harrison, Richard
    Hartopp, Paul
    Kack, Helena
    Leeson, Paul D.
    Luker, Timothy
    Mete, Antonio
    Millichip, Ian
    Nicholls, David J.
    Pimm, Austen D.
    St-Gallay, Steve A.
    Wallace, Alan V.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (08) : 2468 - 2471
  • [5] GW274150 and GW273629 are potent and highly selective inhibitors of inducible nitric oxide synthase in vitro and in vivo
    Alderton, WK
    Angell, ADR
    Craig, C
    Dawson, J
    Garvey, E
    Moncada, S
    Monkhouse, J
    Rees, D
    Russell, LJ
    Russell, RJ
    Schwartz, S
    Waslidge, N
    Knowles, RG
    BRITISH JOURNAL OF PHARMACOLOGY, 2005, 145 (03) : 301 - 312
  • [6] NOVEL POTENT AND SELECTIVE INHIBITORS OF INDUCIBLE NITRIC-OXIDE SYNTHASE
    NAKANE, M
    KLINGHOFER, V
    KUK, JE
    DONNELLY, JL
    BUDZIK, GP
    POLLOCK, JS
    BASHA, F
    CARTER, GW
    MOLECULAR PHARMACOLOGY, 1995, 47 (04) : 831 - 834
  • [7] Aminoethylisoselenourea and related compounds are potent inhibition of the inducible isoform of nitric oxide synthase in vitro and in vivo.
    Southan, GJ
    Salzman, AL
    Szabo, C
    FASEB JOURNAL, 1996, 10 (03): : 2532 - 2532
  • [8] Selective in vivo inhibition of inducible nitric oxide synthase in a rat model of sepsis
    Scott, JA
    McCormack, DG
    JOURNAL OF APPLIED PHYSIOLOGY, 1999, 86 (05) : 1739 - 1744
  • [9] Selective inhibition of inducible nitric oxide synthase by aminoguanidine
    Corbett, JA
    McDaniel, ML
    NITRIC OXIDE, PT A - SOURCES AND DETECTION OF NO; NO SYNTHASE, 1996, 268 : 398 - 408
  • [10] Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase
    Pelletier, JP
    Jovanovic, D
    Fernandes, JC
    Manning, P
    Connor, JR
    Currie, MG
    Di Battista, JA
    Martel-Pelletier, J
    ARTHRITIS AND RHEUMATISM, 1998, 41 (07): : 1275 - 1286
12345